Kelajakdagi narxning foydaga nisbati: gaintherapeutics.com (GANX)

Gain Therapeutics, Inc. (GANX) - korporativ logo

Gain Therapeutics, Inc. (GANX) shifokor nazorati ostida avtomatlashtirilgan moddalar sintezi yordamida markaziy nerv tizimi patologiyalariga qarshi kurashish uchun SEE-Tx IT tizimini ishlab chiqmoqda. AQSh va Shveytsariyadagi operatsiyalar biznes neytralligini va sanksiyalardan himoyalanganligini ta'minlaydi. Kompaniyaning oldingi P/E koeffitsiyenti grafigi ushbu ma'lumotlarni tasdiqlaydi, 0.00 ko'rsatkichi esa emitentning joriy real vaqtdagi bahosini aks ettiradi.

gaintherapeutics.com - GANX Kapitalizatsiyaning kelajakdagi foydaga nisbati (davr: 04.07.2022 - 17.11.2026)

Gain Therapeutics, Inc. kompaniyasining tahliliy kesimlari

- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
Kompaniyaning asosiy tahlili:GANX Gain Therapeutics, Inc.
gaintherapeutics.com brendining mahsuloti

Oldingi P/E koeffitsiyenti joriy bozor kapitalizatsiyasini kutilayotgan foyda bilan bog'laydi, bu esa investorlarga kelajakdagi pul oqimlarini baholash va bozor shovqinlarini filtrlash imkonini beradi. Xarajatlari laboratoriya protokollari va ekologik muvofiqlik bilan cheklangan Gain Therapeutics, Inc. (GANX) uchun ushbu oldingi P/E koeffitsiyenti klinik sinovlarning muvaffaqiyati bo'yicha bozor kutganlarini ko'rsatuvchi indikator vazifasini o'taydi va aktivning haddan tashqari yuqori baholanganlik darajasini belgilaydi.

Gain Therapeutics, Inc. kimlar bilan raqobatlashadi

Kelajakdagi narxning foydaga nisbati HCA Holdings (HCA)|Tenet Healthcare - Narxning kelajakdagi foydaga nisbati|Fresenius Medical Care Corp - Prognoz qilingan narxning foydaga nisbati|SOLV: Narxning kelajakdagi foydaga nisbati|Encompass - Forvard P/E multiplikatori|UHS - Forvard P/E multiplikatori|DVA: Forvard P/E multiplikatori|RadNet Corp - Kelajakdagi narx-foyda multiplikatori|Kelajakdagi narxning foydaga nisbati Option Care Health Inc|Forvard P/E multiplikatori surgerypartners.com|Forvard P/E multiplikatori PINC|Kapitalizatsiyaning prognoz qilingan foydaga nisbati National Vision Holdings, Inc.|Forvard P/E multiplikatori PGNY (Progyny Inc)|Ardent Health Corp (ARDT) - Prognoz qilingan narx-foyda nisbati|SEM: Prognoz qilingan narxning foydaga nisbati|ASTH - Forvard P/E multiplikatori|MD: Forvard P/E multiplikatori|Narxning kutilayotgan foydaga nisbati USPH (US Physical Therapy)|Kelajakdagi narxning foydaga nisbati The Pennant Group, Inc.|ORGO - Forvard narx-foyda multiplikatori|Forvard P/E multiplikatori NUTX|Forvard P/E multiplikatori Auna (AUNA)|Forvard P/E multiplikatori SBC (sbc-holdings.com)|EOLS: Narxning kelajakdagi foydaga nisbati|Community Health Systems Inc - Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati The Beauty Health Company|MediWound Ltd (MDWD) - Kelajakdagi narxning foydaga nisbati|BTMD - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati The Joint|Prognoz qilingan narxning foydaga nisbati DocGo (DCGO)|P3 Health Partners, Inc. (PIII) - Kelajakdagi narx-foyda multiplikatori|Forvard P/E multiplikatori EUDA Health (EUDA)|Basel Medical Group - Prognoz qilingan narxning foydaga nisbati|Kapitalizatsiyaning kelajakdagi foydaga nisbati CLGN (CollPlant Ltd)|cuprina.com.sg - Forvard P/E multiplikatori|Kelajakdagi narx-foyda multiplikatori CCM (Concord Medical Services Holdings)|AMS: Forvard P/E multiplikatori|Prognoz qilingan narx-foyda nisbati MEDIROM Corp (MRM)|ALBT (Avalon GloboCare Corporation) - Forvard P/E multiplikatori|Narxning kelajakdagi foydaga nisbati DHAI (DIH Holding US, Inc.)|Forvard P/E multiplikatori XAGE|Kapitalizatsiyaning prognoz qilingan foydaga nisbati NewGenIvf Group|Kelajakdagi narxning foydaga nisbati ATI Physical Therapy Inc. ATIP|CareMax Medical Group (CMAX) - Prognoz qilingan narx-foyda nisbati|KDLY - Kelajakdagi narxning foydaga nisbati|Kelajakdagi narx-foyda multiplikatori MODV (ModivCare Inc.)|Novo Integrated (NVOS) - Kelajakdagi narxning foydaga nisbati|SSY - Kapitalizatsiyaning prognoz qilingan foydaga nisbati|Kelajakdagi narxning foydaga nisbati IMAC Holdings Inc